Marc B. Aixalà is a telecommunications engineer, psychologist,
psychotherapist and certified Holotropic Breathwork facilitator
specializing in supporting people who face challenging experiences
with expanded states of consciousness. Since 2013, in collaboration
with the International Center for Ethnobotanical Education,
Research and Service (ICEERS), Aixalá has offered integration
psychotherapy sessions for those seeking support after psychedelic
experiences. At ICEERS, Aixalà also works to develop theoretical
models of intervention and trains and supervises
therapists.
Aixalà has served as a team leader and trainer in emergency
psychological assistance at Boom Festival through the Kosmicare
harm reduction program. He also worked on the first-ever medical
trial on the use of psilocybin for treatment-resistant depression,
a study chronicled in the 2018 documentary, “Magic Medicine.” He
continues to work as a therapist in clinical trials researching
psychedelic substances.
Aixalà is trained in the therapeutic use of Non-Ordinary States of
Consciousness as well as in MDMA-assisted psychotherapy for
post-traumatic stress disorder ( PTSD) by the Multidisciplinary
Association for Psychedelic Studies (MAPS). Aixalà works as a
psychologist in his private practice in Barcelona, Spain and offers
trainings, lectures, and talks related to psychedelic psychotherapy
and integration.
José Carlos Bouso is a Clinical Psychologist with a PhD in
Pharmacology. He developed his scientific actitives while at the
Universidad Autónoma de Madrid, the Instituto de Investigación
Biomédica IIB-Sant Pau de Barcelona, and the Instituto Hospital del
Mar de Investigaciones Médicas de Barcelona (IMIM). During this
time, he developed studies about the therapeutic effects of MDMA
(“ecstasy”) and psychopharmacological studies on the acute and
neuropsychiatric long-term effects of many substances, both
synthetic and plant origin. As the Scientific Director at the
International Center for Ethnobotanical Education, Research and
Service (ICEERS), José Carlos oversees studies on the potential
benefits of psychoactive plants, principally cannabis, ayahuasca,
and ibogaine, with the goal of improving public health. He is
co-author of numerous scientific papers and several book chapters.
|
Ask a Question About this Product More... |
|
